NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...
In an interview with Fox News' Sean Hannity, Health and Human Services Secretary Robert F. Kennedy Jr. made several ...
National Vaccination Day, on March 16 in India, marks the 1995 Pulse Polio Immunisation launch, raising awareness about ...
Research found most parents and caregivers support required school vaccines, trust messaging from school nurses, and prefer ...
Raw Story on MSN9d
‘Unsatisfactory’: Bannon lashes out at Trump for pulling vaccine critic as CDC nomineeMAGA influencer and former White House adviser Steve Bannon lashed out at President Donald Trump's White House after the ...
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as ...
Merck & Co Inc (NYSE:MRK) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
According to Arizton’s latest research report, the lipid-based pharma excipients market is growing at a CAGR of 5.63% during ...
Harrow , a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development ("SSD") agreement for TRIESENCE® (triamcinolone acetonide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback